Clinical Trial

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

Study acronym: IMPULSE-EVO
Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, prospective, single-arm, feasibility study to evaluate the safety and effectiveness of the waveforms being delivered using the FARAPULSE PFA System in patients with Paroxysmal Atrial Fibrillation (PAF) and Persistent Atrial Fibrillation (PersAF).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2026-02-26; most recent amendment 2026-07-24.
Trial Details
NCT Number NCT07444320
Lead Sponsor Boston Scientific Corporation
Conditions Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Enrollment 200 participants
Start Date 2026-02-12
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-27